OmnySense

Company Overview

Snapshot

Founded in May 2019 by Yossi Aldar, Ian Solomon, and Amir Elhasid, OmnySense is a digital health company with 1–10 employees. The company has raised $1.5M across two funding rounds and holds a US patent on its smart thermometer with integrated 3/6-lead ECG, awarded in November 2024.

Business overview

OmnySense develops a digital health solution featuring a smart multi-sensor device and an AI-powered app designed to measure and interpret key clinical parameters. This technology enables individuals to conduct health assessments at home, facilitating informed decisions about when to seek medical attention. The company focuses on creating structured, contextual, and clinically meaningful Real-World Physiological Data, serving individuals, healthcare systems, and the broader health industry within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Monitors.

Strategic signal

OmnySense is poised to significantly impact respiratory health tracking and oncology patient care. In March 2025, the company announced its patented technology is set to disrupt respiratory health tracking, while also targeting oncology patients as an initial focus for its transformative personal health-assessment solution. This strategic dual focus indicates OmnySense's intent to leverage its technology for critical health monitoring, potentially expanding its market reach and clinical utility in high-need areas.

Company Intelligence Q&A

What is OmnySense's core product?

OmnySense offers a smart multi-sensor device paired with an AI-powered app that measures and interprets key clinical parameters, providing immediate medical assessments at home.

When was OmnySense awarded a key patent?

In November 2024, OmnySense was awarded a US patent for its smart thermometer, which features an integrated 3/6-lead ECG.

What is OmnySense's strategic focus for its personal health-assessment solution?

In March 2025, OmnySense announced its intention to target oncology patients as an initial focus for its transformative personal health-assessment solution.

What was a recent validation of OmnySense's respiratory assessment method?

In August 2024, a study confirmed OmnySense’s innovative and practical method for performing respiratory assessment at home.

How does OmnySense leverage AI in its technology?

In September 2024, OmnySense announced it leverages Medical Large Language Models (Med LMs) to deliver immediate medical assessments at home.